(Q83172530)

English

A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer

scientific article published on 12 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Xin Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kai Mei

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Xiaohong Cai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jing Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jingrui Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Chengya Zhou

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Qiu Li

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

12 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1144-1149

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225314%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

https://scigraph.springernature.com/pub.10.1007/s10637-011-9631-7

0 references

Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor angiogenesis: therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225314

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83172530&oldid=1408055784"